<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04359576</url>
  </required_header>
  <id_info>
    <org_study_id>TromboFET</org_study_id>
    <nct_id>NCT04359576</nct_id>
  </id_info>
  <brief_title>Frozen-thawed Embryo Transfers and Hormone Substitution on Thrombotic Risk Markers</brief_title>
  <acronym>TromboFET</acronym>
  <official_title>Impact of Frozen-thawed Embryo Transfers and Hormone Substitution on Thrombotic Risk Markers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Horsens Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Aarhus University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Horsens Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study focus on the impact of estrogen/progesterone substitution during artificial cycle
      frozen embryo transfer (AC-FET) in women undertaking assisted reproductive technology
      treatment (ART).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim is to investigate whether the coagulation is activated in women undergoing
      estrogen/progesterone substitution during artificial cycle frozen embryo transfer (AC-FET) in
      assisted reproductive technology treatment (ART). An activation of the coagulation might
      induce an increased thromboembolic risk in these women. Thus, the present study may lead to
      improvement of the current treatment protocol for women receiving AC-FET and ultimately
      prevent thromboembolic complications for woman in fertility treatment.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 1, 2019</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">January 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>coagulation</measure>
    <time_frame>1 year</time_frame>
    <description>Primary and secondary hemostasis parameters</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Frozen Embryo Transfer</condition>
  <arm_group>
    <arm_group_label>FET</arm_group_label>
    <description>Estrogen/progesterone substituted and natural cycles</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Primary and secondary hemostasis</intervention_name>
    <description>Focus on platelet aggregation, primary and secondary hemostasis parameters</description>
    <arm_group_label>FET</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Healthy women receiving FET
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women receiving FET with or without estrogen/progesterone substitution

        Exclusion Criteria:

          -  Known bleeding disorder

          -  Indication for thromboprophylaxis during ART treatment

          -  Treatment with anti-platelet medication including non-steroid-anti-inflammatory drugs
             (NSAIDs) within the last week

          -  Donor recipients
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>U Knudsen, Professor</last_name>
    <phone>+4530720656</phone>
    <email>ullaknud@rm.dk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>A M Hvas, Professor</last_name>
    <phone>+4521186893</phone>
    <email>annehvas@rm.dk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Horsens Regional Hospital</name>
      <address>
        <city>Horsens</city>
        <zip>8700</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Line Jensen</last_name>
      <phone>+45 7842 6103</phone>
      <email>linejen8@rm.dk</email>
    </contact>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>April 21, 2020</study_first_submitted>
  <study_first_submitted_qc>April 21, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 24, 2020</study_first_posted>
  <last_update_submitted>April 23, 2020</last_update_submitted>
  <last_update_submitted_qc>April 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Horsens Hospital</investigator_affiliation>
    <investigator_full_name>Ulla Breth Knudsen</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemostatics</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

